Mindfulness-based Educational Intervention on Anxiety, Depression, Stress and Quality of Life on Menopausal Woman
Launched by ALEXANDRIA UNIVERSITY · May 15, 2024
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a mindfulness-based educational program on menopausal women. The program aims to help participants manage symptoms like anxiety, depression, and stress while improving their overall quality of life. By practicing mindfulness, participants will learn how to pay attention to their thoughts and feelings without judgment, which can lead to better emotional health and well-being.
To join the trial, women between the ages of 18 and 70 who are experiencing menopause are eligible. Participants can expect to engage in mindfulness meditation, learn stress management techniques, and receive education on emotional regulation. This structured program provides a supportive environment to help women cope with the challenges of menopause. If you're interested in learning more or considering participation, this trial could offer valuable resources for managing your symptoms.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • in age of menopause
- Exclusion Criteria:
- • age of menarche
- • older than 70 years old
About Alexandria University
Alexandria University, a leading academic institution in Egypt, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive resources and expertise to conduct rigorous studies that address pressing health challenges. By fostering partnerships with healthcare professionals, industry leaders, and regulatory bodies, Alexandria University aims to contribute to the global body of medical knowledge and enhance the quality of patient care through evidence-based findings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alexandria, Al Iskandariyah, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported